CD82 and breast carcinoma: This finding is in accordance with the study by Zhang et al., (2012) who demonstrated that the KAI-1 expression was down-regulated in breast cancer tissues and the patients with LNM shown decreased KAI-1 expression as compared to the patients without LNM (Zhang et al., 2012).